CME Information

Activity Title Credit Extender-Practice Improvement Tool
Topic Stroke and Atrial Fibrillation
Target Audience Cardiologists and other health care professionals managing patients with atrial fibrillation
Accreditation Type CME
Release Date August 2010
Expiration Date August 31, 2011
Estimated Time to Complete Activity 30 minutes

LEARNING OBJECTIVES

Upon completion of the activity, participants should be able to:

  • Utilize available stroke risk stratification schemes to further identify risk profiles among patients within your clinical practice
  • Describe the current utilization rates of anticoagulants for the prevention of stroke among patients with AF and the risks associated with underutilization of these agents
  • Identify clinically significant barriers faced in clinical practice that impede adherence to AF treatment guidelines for the prevention of stroke and discuss ways to overcome these barriers
  • Describe the novel targets in the coagulation cascade that are the basis for newer antithrombotic therapies and discuss their potential implications for stroke prevention among AF patients

Faculty

Maria I. Aguilar, MD
Assistant Professor of Neurology
Mayo Clinic College of Medicine
 
Consultant
Division of Cerebrovascular Diseases
Department of neurology
Mayo Clinic
Scottsdale, Arizona

Jack E. Ansell, MD
Michael S. Bruno, MD Chairman of the Department of Medicine
Lenox Hill Hospital
New York, New York

N. A. Mark Estes, MD
Director
New England Cardiac Arrhythmia Center
Cardiac Electrophysiology and
Pacemaker Laboratory
Tufts Medical Center
 
Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME information.
  3. Complete the CME activity.
  4. Complete the CME evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  5. Your CME certificate will be emailed to you.

CLICK HERE TO VIEW TECHNICAL REQUIREMENTS

SPONSOR

This activity is sponsored by the University of Nebraska Medical Center, Center for Continuing Education and The France Foundation.

TARGET AUDIENCE

This educational activity has been planned in accordance with the need to provide cardiologists and other health care professionals managing patients with atrial fibrillation with important information on stroke prevention among patients with AF.

STATEMENT OF NEED

Antithrombotic therapy is a very important consideration for AF patients, particularly in light of the high risk for stroke. Yet, despite an abundance of evidence, there continues to be underutilization of anticoagulation in patients with AF and many missed opportunities for preventing disabling, and often fatal, strokes among these patients. This education will help cardiologists manage their patients with atrial fibrillation.

ACCREDITATION STATEMENT

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

RESOLUTION OF CONFLICTS OF INTEREST

In accordance with the ACCME Standards for Commercial Support of CME, The University of Nebraska Medical Center, Center for Continuing Medical Education and The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

DISCLOSURE

It is the policy of The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, and staff involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation have identified and resolved any and all conflicts of interest prior to the release of this activity.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at the University of Nebraska Medical Center, Center for Continuing Medical Education who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

The following faculty have indicated they have no relationships with industry to disclose relative to the content of this CME activity:

  • Maria I. Aguilar, MD

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:

  • Jack E. Ansell, MD, FACP, has served as a consultant for Bayer, Bristol-Myers Squibb, and Johnson & Johnson. He has received honoraria from sanofi-aventis.
  • N. A. Mark Estes III, MD, FACC, FAHA, FHRS, has received honoraria and other financial support from Boston Scientific.

UNAPPROVED USE DISCLOSURE

The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation require CME faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by an educational grant from Boehringer Ingelheim.

DISCLAIMER

The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education, The France Foundation, and Boehringer Ingelheim assume no liability for the information herein.

COPYRIGHT INFORMATION

Copyright © 2010 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.

PRIVACY POLICY

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.

CONTACT INFORMATION

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.

 

To begin: